Peptides identified through phage display direct immunogenic antigen to dendritic cells

被引:84
作者
Curiel, TJ
Morris, C
Brumlik, M
Landry, SJ
Finstad, K
Nelson, A
Joshi, V
Hawkins, C
Alarez, X
Lackner, A
Mohamadzadeh, M
机构
[1] Tulane Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA 70112 USA
[2] Tulane Univ, Hlth Sci Ctr, Dept Microbiol, New Orleans, LA 70112 USA
[3] Tulane Univ, Hlth Sci Ctr, Dept Biochem, New Orleans, LA 70112 USA
[4] Tulane Natl Primate Res Ctr, New Orleans, LA 70112 USA
关键词
D O I
10.4049/jimmunol.172.12.7425
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DC) play a critical role in adaptive immunity by presenting Ag, thereby priming naive T cells. Specific DC-binding peptides were identified using a phage display peptide library. DC-peptides were fused to hepatitis C virus nonstructural protein 3 (NS3) while preserving DC targeting selectivity and Ag immunogenicity. The NS3-DC-peptide fusion protein was efficiently presented to CD4(+) and CD8(+) T cells derived from hepatitis C virus-positive blood cells, inducing their activation and proliferation. This immunogenic fusion protein was significantly more potent than NS3 control fusion protein or NS3 alone. In chimeric NOD-SCID mice transplanted with human cells, DC-targeted NS3 primed naive CD4(+) and CD8(+) T cells for potent NS3-specific proliferation and cytokine secretion. The capacity of peptides to specifically target immunogenic Ags to DC may establish a novel strategy for vaccine development.
引用
收藏
页码:7425 / 7431
页数:7
相关论文
共 28 条
[1]   Steps toward mapping the human vasculature by phage display [J].
Arap, W ;
Kolonin, MG ;
Trepel, M ;
Lahdenranta, J ;
Cardó-Vila, M ;
Giordano, RJ ;
Mintz, PJ ;
Ardelt, PU ;
Yao, VJ ;
Vidal, CI ;
Chen, L ;
Flamm, A ;
Valtanen, H ;
Weavind, LM ;
Hicks, ME ;
Pollock, RE ;
Botz, GH ;
Bucana, CD ;
Koivunen, E ;
Cahill, D ;
Troncoso, P ;
Baggerly, KA ;
Pentz, RD ;
Do, KA ;
Logothetis, CJ ;
Pasqualini, R .
NATURE MEDICINE, 2002, 8 (02) :121-127
[2]   Dendritic cells as vectors for therapy [J].
Banchereau, J ;
Schuler-Thurner, B ;
Palucka, AK ;
Schuler, G .
CELL, 2001, 106 (03) :271-274
[3]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[4]  
Böcher WO, 2001, EUR J IMMUNOL, V31, P2071, DOI 10.1002/1521-4141(200107)31:7<2071::AID-IMMU2071>3.0.CO
[5]  
2-D
[6]   Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance [J].
Bonifaz, L ;
Bonnyay, D ;
Mahnke, K ;
Rivera, M ;
Nussenzweig, MC ;
Steinman, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (12) :1627-1638
[7]   CD34(+) hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha [J].
Caux, C ;
Vanbervliet, B ;
Massacrier, C ;
DezutterDambuyant, C ;
deSaintVis, B ;
Jacquet, C ;
Yoneda, K ;
Imamura, S ;
Schmitt, D ;
Banchereau, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :695-706
[8]   GM-CSF AND TNF-ALPHA COOPERATE IN THE GENERATION OF DENDRITIC LANGERHANS CELLS [J].
CAUX, C ;
DEZUTTERDAMBUYANT, C ;
SCHMITT, D ;
BANCHEREAU, J .
NATURE, 1992, 360 (6401) :258-261
[9]   Origin, maturation and antigen presenting function of dendritic cells [J].
Cella, M ;
Sallusto, F ;
Lanzavecchia, A .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) :10-16
[10]   Tumor immunotherapy: inching toward the finish line [J].
Curiel, TJ ;
Curiel, DT .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (03) :311-312